Zentree Investments Limited 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 09:19 am Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | Zentree Investments Limited | 1,596,056 12.598% | 304,244 (+23.55%) | Filing |
| 2022-12-20 06:01 am Purchase | 2022-12-15 | 13G | Orchard Therapeutics plc ORTX | Zentree Investments Limited | 1,291,812 10.197% | 644,065 (+99.43%) | Filing |
| 2022-09-09 10:11 am Purchase | 2022-09-01 | 13G | Orchard Therapeutics plc ORTX | Zentree Investments Limited | 647,747 5.122% | 647,747 (New Position) | Filing |